Efficacy and Safety of Intralesional Triamcinolone Acetonide Injection in the Treatment of Alopecia Areata

The study investigated the efficacy and safety of intralesional Triamcinolone acetonide injections in treating alopecia areata (AA) in 36 patients. The treatment involved injecting 5 mg/ml of Triamcinolone acetonide every 4 weeks, with clinical assessments conducted monthly. Results showed that 5.6% of patients had an excellent response, 5.6% had a very good response, 55.6% had a good response, 5.6% had a moderate response, 16.7% had a mild response, and four patients had a poor response. Side effects were minimal, including pain and atrophy in 11.1% of patients. The study concluded that intralesional Triamcinolone acetonide injection was a safe and effective treatment for AA.